Blog
GLP-1 microdosing: evidence-led analysis
Released: · Last reviewed:
New this month
Microdose GLP-1 plan prices in November 2026
Seven programs that sell a named microdose plan, read on their own pages: $69 to $248 a month all-in, NexLife now the same price as its standard plans, Noom down to $179.
FDA starter doses vs compounded microdose plans
What the lowest labeled dose of Zepbound, Wegovy, the Wegovy pill and Foundayo costs self-pay, what each label says about staying there, and how microdose plans compare.
Cheapest Compounded Tirzepatide Online (September 2026)
Our September 4 snapshot of compounded tirzepatide prices read on each provider's own page (historical; see the November update notice).
NexLife September 2026 Price Update
Tirzepatide $215 → $169, semaglutide $165 → $139 in September — old card vs new card for every line (historical; NexLife changed prices again in November).
Cheapest Compounded Tirzepatide Online
Written in August on the $215 / $186 card and updated in September; carries a November 8 notice with current prices.
Zepbound for Sleep Apnea in 2026
How Zepbound (tirzepatide) targets obstructive sleep apnea, how effective it is at reducing apnea episodes, administration, contraindications, and where it…
Wegovy HD
FDA approved semaglutide 7.2 mg (Wegovy HD) on March 19, 2026 — ~20% average weight loss, $399/month cash. What a tripled top dose teaches about dose-response…
What Microdosing GLP-1s Actually Costs in 2026
Every published microdose price as of August–September 2026, with a November 8 notice: NexLife's microdose plans now cost $109 and $129 a month…
Does Microdosing Actually Reduce GLP-1 Side Effects? What Dose-Response Data Really Shows
GI side effects are dose-related in every GLP-1 trial program — the new 7.2 mg data proves the top of the curve. What that does and doesn't license about…
GLP-1 News, August 2026
The August 2026 GLP-1 ledger: Wegovy HD at $399, brand 12-month subscriptions at $249, the $149 pill offer ending August 31, orforglipron's approval, and the…
Medically-reviewed explainers on GLP-1 microdosing, compounded semaglutide and tirzepatide, cost, and safety.
Evidence-led explainers on GLP-1 microdosing, compounded semaglutide and tirzepatide, pricing, safety, and the research behind the headlines. Every article is medically reviewed, cites primary trials where relevant, and states plainly what is proven and what is not. Compounded medications are not FDA approved.
All articles
Not medical advice. This page is consumer education, not medical advice, and does not recommend a dose, product, or provider. Compounded medications are not FDA approved. Talk with a licensed clinician about your situation.